Skip to main content
. Author manuscript; available in PMC: 2022 Sep 15.
Published in final edited form as: Cancer Res. 2022 Mar 15;82(6):1038–1054. doi: 10.1158/0008-5472.CAN-21-0622

Figure 1: LRRC15 is associated with ovarian cancer.

Figure 1:

(A) Kaplan-Meier progression free survival (PFS) analysis shows high LRRC15 expression is associated with worse PFS in a cohort of 1436 OC patients. (B) TCGA analysis of LRRC15 expression in several cancer types along with the percent gene altered as evaluated in the ovarian epithelial tumor. (C-D) Immunoblot analysis of LRRC15 in OC cell lines and in the OC fibroblast cell lines NOF15hTERT and TRS3 and in the normal ovarian surface epithelial cells VOSE and IOSE523. β-actin was used as loading control. (E) Western blot analysis of LRRC15 and PCNA expression as control in 10 OC PDX tumors.